REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 18 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Publishers | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Dr.Max 18 S.R.O. Profile Updated: July 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 18 S.R.O. is based in Slovakia. The head office is in Kosice. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on February 23, 2011. 3 - 4 (2025) employees currently work for Dr.Max 18 S.R.O.. From the latest financial highlights, Dr.Max 18 S.R.O. reported a net sales revenue increase of 9.06% in 2024. There was a total growth of 20.23% in Dr.Max 18 S.R.O.’s total assets over the same period. The net profit margin of Dr.Max 18 S.R.O. increased by 0.32% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 18 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 18 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 18 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 18 S.R.O. report to view the information.
Incorporation Date:
February 23, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 18 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.06%▲
Total operating revenue
9.01%▲
Operating profit (EBIT)
30.53%▲
EBITDA
13.33%▲
Net Profit (Loss) for the Period
32.75%▲
Total assets
20.23%▲
Total equity
23.11%▲
Operating Profit Margin (ROS)
0.35%▲
Net Profit Margin
0.32%▲
Return on Equity (ROE)
1.37%▲
Debt to Equity Ratio
-0.11%▼
Quick Ratio
0.02%▲

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Pharm S.R.O.
 
Benu Sk 91, S.R.O.
Lekaren - Hlavna Sala, S.R.O.
 
Novea Pharm S.R.O.
Lekaren Simba, S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo